Common steroids after ‘long COVID’ recovery may halve your death risk
Scientists from the University of Florida found that among patients hospitalized for COVID-19 who seemingly recovered, severe systemic inflammation during their hospitalization is a risk factor...
People with mild COVID-19 need to use antiviral drug to treat disease
In a recent study from WHO, researchers suggest that Pfizer’s oral antiviral drug (a combination of nirmatrelvir and ritonavir tablets) is strongly recommended for...
Scientists find the key to preventing, treating severe COVID-19
Scientists from The Ohio State University found that blocking an immune response-related enzyme holds promise in preventing or treating severe COVID-19 symptoms by reducing...
First head-to-head comparison of four COVID-19 vaccines
Scientists from La Jolla Institute for Immunology reported the first analysis of how four types of COVID-19 vaccines prepare the body to fight SARS-CoV-2.
Their...
These people have best COVID-19 protection, study finds
In a recent study from the Federal University of Mato Grosso do Sul, researchers found that people with the “hybrid immunity” of having been...
People who get COVID-19 could have antibodies for 500 days
Scientists from the University of Texas found that adults who get COVID-19 could have antibodies circulating in their blood for nearly 500 days after...
Breakthrough COVID infections more likely in these people
Scientists from Case Western Reserve University found that breakthrough COVID-19 cases resulting in infections, hospitalizations and deaths are much more likely in cancer and...
End of strict COVID measures in China could result in 1.5 million deaths in...
In a new study published in Nature Medicine, researchers revealed that if China rescinds Zero-COVID policies, the country’s healthcare system will almost certainly be...
Kidney injury from COVID-19 may be twice as common as diagnosed
Scientists from the University of Queensland found millions of COVID-19 patients may have undiagnosed acute kidney injury (AKI).
The research is published in PLOS Medicine...
Vaccines have up to 90% efficacy against severe COVID-19 for up to 6 months
Scientists from Penn State found that protection against symptomatic COVID-19 begins to decrease after one month from initial vaccination, while immunity against severe COVID-19...